TrialIntensive care medicine2024

Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP).

Sebastian Rehberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.